ilmofosine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dadey, ML; Gams, RA; McPhillips, JJ; Rodriguez, GI; Rowe, KW; Schultz, CJ; Von Hoff, DD; Woolley, PV | 1 |
| Berges, W; Ebeling, K; Hottenrott, G; Mechl, Z; Schlimok, G; Scholten, T; Sterz, R; Strohmeyer, G; Westerhausen, M; Winkelmann, M | 1 |
2 trial(s) available for ilmofosine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Phospholipid Ethers | 1996 |
Treatment results of the thioether lipid ilmofosine in patients with malignant tumours.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Drug Evaluation; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Pancreatic Neoplasms; Phospholipid Ethers | 1992 |